Delaware House Bill 383

---

Spectrum: Partisan Bill (Democrat 12-0)
Status: Introduced on May 2 2024 - 25% progression
Action: 2024-05-14 - Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 6 On Its Merits, 1 Unfavorable
Text: Latest bill text (Draft #1) [HTML]

Section 1 of this Act prohibits discrimination against 340B drug distribution by manufacturers, repackagers, third-party logistics providers, and wholesalers. Violations are deemed an unlawful practice enforceable by the Consumer Protection Unit of the Department of Justice. The Department of Justice has authority to promulgate regulations under this section. The Board of Pharmacy may take disciplinary action against licensees based on the outcome of investigations or proceedings brought by the Department of Justice.

An Act To Amend Titles 18 And 24 Of The Delaware Code Relating To Prohibiting Discrimination Against 340b Drugs And Covered Entities By Manufacturers And Pharmacy Benefits Managers.

Rep. Kerri Harris [D]	Sen. Sarah McBride [D]	Sen. Nicole Poore [D]	Rep. Sherry Dorsey Walker [D]
Rep. Kendra Johnson [D]	Rep. Melissa Minor-Brown [D]	Rep. Eric Morrison [D]	Rep. DeShanna Neal [D]
Rep. Cyndie Romer [D]	Rep. Madinah Wilson-Anton [D]	Rep. Paul Baumbach [D]	Rep. Larry Lambert [D]

Date	Chamber	Action
2024-05-14		Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 6 On Its Merits, 1 Unfavorable
2024-05-02		Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

Type	Source
Summary	https://legis.delaware.gov/BillDetail?LegislationId=141279
Text	https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=141279&legislationTypeId=1&docTypeId=2&legislationName=HB383